About UsCompany OverviewLeadership TeamEcosystem & ImpactCareers
SciencepLNP TechnologyEnsaliX PlatformPipeline & ApplicationsPublications
PartnershipWhy Partner With UsHow to PartnerPartner JourneyStart a Partnership
Our ProductsEnsaliX Chips
NewsroomNewsPublicationsPress Releases
NanoPalm researcher in the laboratory
The Science

Science Behind NanoPalm

NanoPalm's science combines AI-driven formulation design and nanocontact printing technology to manufacture patterned lipid nanoparticles with precision.

Patterned Lipid Nanoparticles

From raw lipids to patterned LNPs — EnsaliX Chips are pre-formulated, AI-designed patterned lipids produced by nanocontact printing, engineered for stability, safety, and selectivity without ionizable lipids or active-targeting ligands.

EnsaliX AI platform analyzing microscopic imaging data

Tailored AI-Driven Designs of pLNPs

EnsaliX predicts novel pLNP formulations based on the disease microenvironment — accelerating R&D and reducing trial-and-error experimentation.

01

EnsaliX AI Design

Trained on a large LNP dataset using machine learning, computer vision, and predictive analytics. Predicts customized pLNP formulations for each payload, target tissue, and route.

→ Formulation recommendation + technical report
02

pLNP Chips Manufacturing

Semi-solid patterned lipid chips produced by nanocontact printing — controlling size, shape, and surface chemistry for consistency and stability.

→ Manufactured pLNP Chips
03

pLNP Formation & Loading

EnsaliX Chips formulate therapeutic doses with improved stability, safety, and self-targeting beyond the liver — no active targeting ligands.

pLNP ready for preclinical evaluation

A Track Record of Co-Development

NanoPalm advances partnered programs through co-development collaborations with early adopters supporting clinical translation.

AssetPartnerTherapeutic AreaModalityRouteStageStrategy
1Rakovina TherapeuticsOncologySmall MoleculeIV Pre-clinical Partnership
2NevezyneVaccinePeptideIV Lead optimization Partnership
3Adjuva BioGene TherapymRNAIV Lead optimization Partnership
4UndisclosedUndisclosedDNA Discovery Partnership
5UndisclosedUndisclosedAntibody Discovery Partnership

Stage progression: Discovery → Lead optimization → Preclinical → IND Studies 

Knowledge & Updates

Explore the latest from NanoPalm — company news, press releases, and peer-reviewed research.